About 10 weeks after it was approved, the Wegovy pill is now estimated to be part of the daily regimen of about 400,000 ...

A new clinical trial is exploring a different strategy for tackling one of obesity treatment’s biggest challenges: keeping weight off after initial success.

A new class of weight loss drug just took a major step toward approval for use. In a phase III clinical trial, medication ...

Jo Dee Messina says that she knew she wanted to lose weight after realizing she 'didn't recognize myself' in photos, the ...

A new study suggests that almost half of people stopping GLP-1 weight-loss drugs may keep the weight off. However, many of ...

The high-dose Wegovy helped patients with obesity lose an average 20.7% of their weight after 72 weeks in a phase three trial.

A stronger version of the popular weight loss drug Wegovy is on the way after federal regulators signed off on a higher dose.

They may do more harm than good.

Savannah Chrisley has been very candid about how she achieved her weight loss, and has shared that both liposuction and GLP-1 ...